• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    8.52 Down 0.04(0.47%) Aug 4, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.56
    Open:8.74
    Bid:7.00 x 100
    Ask:N/A
    1y Target Est:9.50
    Beta:2.07
    Next Earnings Date: 6-Aug-15PGNX Earnings announcement
    Day's Range:8.43 - 8.84
    52wk Range:4.26 - 11.15
    Volume:901,011
    Avg Vol (3m):1,434,910
    Market Cap:593.38M
    P/E (ttm):189.33
    EPS (ttm):0.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNXDown 0.47%593.38M
    NKTRDown 1.19%1.63B

    Key Statistics

    Forward P/E (1 yr):852.00
    P/S (ttm):13.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.68

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology in the United States and internationally. The company’s primary clinical-stage product candidates include prostate specific membrane antigen (PSMA) antibody-drug conjugate, which... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback